Diagnosis and treatment of pediatric pulmonary arterial hypertension.


Journal

Expert review of cardiovascular therapy
ISSN: 1744-8344
Titre abrégé: Expert Rev Cardiovasc Ther
Pays: England
ID NLM: 101182328

Informations de publication

Date de publication:
Mar 2019
Historique:
pubmed: 31 1 2019
medline: 4 4 2019
entrez: 31 1 2019
Statut: ppublish

Résumé

Pediatric pulmonary arterial hypertension (PAH) remains a rare and severe disease with a poor prognosis. PAH may be idiopathic, heritable or associated with systemic conditions in particular associated with congenital heart disease. Areas covered: A thorough and extensive diagnostic approach is required for a correct diagnosis. The outcome has improved over the last decade with a better diagnostic approach and with the initiation of new targeted therapies. However, there is still significant progress to achieve as there is still no cure for this devastating disease. Expert opinion: Adapted clinical studies to define the best therapeutic approach are needed. Even if the treatment approach is still mainly derived from adult data and expert consensus, several studies and registries are currently underway and should deliver important information in the next future. This review aims to give an overview of the current diagnosis and treatment strategies of PAH.

Identifiants

pubmed: 30698043
doi: 10.1080/14779072.2019.1576523
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

161-175

Auteurs

Nesrine Farhat (N)

a Pediatric Cardiology Unit , University Children's Hospital of Geneva , Geneva , Switzerland.

Frederic Lador (F)

b Pulmonary Hypertension Program , University Hospital of Geneva , Geneva , Switzerland.
c Service de Pneumologie , University Hospital of Geneva , Geneva , Switzerland.

Maurice Beghetti (M)

a Pediatric Cardiology Unit , University Children's Hospital of Geneva , Geneva , Switzerland.
c Service de Pneumologie , University Hospital of Geneva , Geneva , Switzerland.
d Centre Universitaire Romand de Cardiologie et Chirurgie Cardiaque Pédiatrique , University of Geneva and Lausane Switzerland , Geneva , Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH